Table 1 Patient characteristics categorized by MSI (N = 742)
N = 742 | Without MSI | With MSI n =180 | P Value | |||
|---|---|---|---|---|---|---|
0(n = 562) | 1(n = 119) | 2(n = 38) | 3(n = 23) | |||
Age(Y) | 0.397 | |||||
<46 | 367 | 279 | 61 | 19 | 8 | |
(49.46%) | (49.64%) | (51.26%) | (50.00%) | (34.78%) | ||
> = 46 | 375 | 283 | 58 | 19 | 15 | |
(50.54%) | (50.36%) | (48.74%) | (50.00%) | (65.22%) | ||
UICC 7th T | <0.001 | |||||
T1, T2 | 308 | 292 | 15 | 0 | 0 | |
(41.51%) | (51.96%) | (12.61%) | (0) | (0) | ||
T3, T4 | 434 | 270 | 104 | 38 | 23 | |
(58.49%) | (48.04%) | (87.39%) | (100%) | (100%) | ||
UICC 7th N | 0.047 | |||||
N0, N1 | 554 | 413 | 89 | 32 | 20 | |
(74.66%) | (73.49%) | (74.79%) | (84.21%) | (86.96%) | ||
N2, N3 | 188 | 149 | 30 | 6 | 3 | |
(25.34%) | (26.51%) | (25.21%) | (15.79%) | (13.04%) | ||
Chemotherapy | <0.001 | |||||
No | 200 | 184 | 13 | 1 | 2 | |
(26.95%) | (32.74%) | (10.92%) | (2.63%) | (8.70%) | ||
Induction | 217 | 143 | 42 | 24 | 8 | |
(29.25%) | (25.44%) | (35.29%) | (63.16%) | (34.78%) | ||
Induction + CCRT | 112 | 69 | 27 | 8 | 8 | |
(15.09%) | (12.28%) | (22.69%) | (21.05%) | (34.78%) | ||
Induction + Adjuvant | 9 | 8 | 1 | 0 | 0 | |
(1.21%) | (1.42%) | (0.84%) | (0) | (0) | ||
CCRT | 171 | 132 | 32 | 4 | 3 | |
(23.05%) | (23.49%) | (26.89%) | (10.53%) | (13.04%) | ||
CCRT + Adjuvant | 16 | 13 | 2 | 0 | 1 | |
(2.16%) | (2.31%) | (1.68%) | (0) | (4.35%) | ||
Induction + CCRT + Adjuvant | 16 | 12 | 2 | 1 | 1 | |
(2.16%) | (2.14%) | (1.68%) | (2.63%) | (4.35%) | ||
Adjuvant | 1 | 1 | 0 | 0 | 0 | |
(0.13%) | (0.18%) | (0) | (0) | (0) | ||